BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 12042878)

  • 1. Oestrogen as a neuroprotective hormone.
    Behl C
    Nat Rev Neurosci; 2002 Jun; 3(6):433-42. PubMed ID: 12042878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex hormones, neuroprotection and cognition.
    Behl C
    Prog Brain Res; 2002; 138():135-42. PubMed ID: 12432767
    [No Abstract]   [Full Text] [Related]  

  • 3. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
    Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
    J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and the aging brain.
    Bondy SC; Sharman EH
    Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-initiated signaling of estrogen in the brain.
    Rønnekleiv OK; Malyala A; Kelly MJ
    Semin Reprod Med; 2007 May; 25(3):165-77. PubMed ID: 17447206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
    Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM
    Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective estrogen receptor modulators as brain therapeutic agents.
    Arevalo MA; Santos-Galindo M; Lagunas N; Azcoitia I; Garcia-Segura LM
    J Mol Endocrinol; 2011 Feb; 46(1):R1-9. PubMed ID: 21071476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial mechanisms of estrogen neuroprotection.
    Simpkins JW; Dykens JA
    Brain Res Rev; 2008 Mar; 57(2):421-30. PubMed ID: 17512984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation.
    Rainey-Smith S; Schroetke LW; Bahia P; Fahmi A; Skilton R; Spencer JP; Rice-Evans C; Rattray M; Williams RJ
    Neurosci Lett; 2008 Jun; 438(1):29-33. PubMed ID: 18467030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target.
    Arnold S; Beyer C
    J Neurochem; 2009 Jul; 110(1):1-11. PubMed ID: 19457121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of estrogens on neurodegenerative processes.
    Członkowska A; Ciesielska A; Joniec I
    Med Sci Monit; 2003 Oct; 9(10):RA247-56. PubMed ID: 14523340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ageing, oestrogen, platelets and thrombotic risk.
    Miller VM; Jayachandran M; Owen WG
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):814-21. PubMed ID: 17600564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Blumenfeld Z
    J Neurochem; 2007 Nov; 103(3):962-71. PubMed ID: 17680997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From structural biochemistry to expression profiling: neuroprotective activities of estrogen.
    Manthey D; Behl C
    Neuroscience; 2006; 138(3):845-50. PubMed ID: 16343783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.
    Brann DW; Dhandapani K; Wakade C; Mahesh VB; Khan MM
    Steroids; 2007 May; 72(5):381-405. PubMed ID: 17379265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
    J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
    Xia Y; Xing JZ; Krukoff TL
    Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection.
    Marin R; Guerra B; Alonso R; Ramírez CM; Díaz M
    Curr Neurovasc Res; 2005 Oct; 2(4):287-301. PubMed ID: 16181121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cystatin C prevents oxidative stress-induced death in PC12 cells.
    Nishiyama K; Konishi A; Nishio C; Araki-Yoshida K; Hatanaka H; Kojima M; Ohmiya Y; Yamada M; Koshimizu H
    Brain Res Bull; 2005 Sep; 67(1-2):94-9. PubMed ID: 16140167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.